Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
about
The ornithodorin-thrombin crystal structure, a key to the TAP enigma?Salivating for knowledge: potential pharmacological agents in tick salivaImportance of factor Xa in determining the procoagulant activity of whole-blood clots.Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Novel inhibitors of factor X for use in cardiovascular diseases.Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis.Specific thrombin inhibitors in vivo.New antithrombotic strategies for resistant thrombotic processes.Thrombosis and fibrinolysis in acute myocardial infarction.NMR structure determination of tick anticoagulant peptide (TAP).Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.Macromolecular complex assembly of prothrombinase is a central process of thrombosis.
P2860
Q27734084-98735B05-D60E-4ECD-926C-C48FDB6AD64FQ33319614-903561DB-CF2A-45E2-9048-562469A0AB67Q33897911-C7CE745F-98EF-45EA-9A78-FF262CFA72DFQ33905952-EC29869B-F0F4-4D05-BC12-687E83340BAFQ34027530-94503A27-6A39-4751-BC96-56E50FA831F3Q35834323-5A46FF77-0DCC-4E72-819E-4572EB9A1B09Q35873710-18776E13-2F35-4579-A5E2-CEFED39DF607Q40664734-F88F599B-AE99-4151-9B09-4FCAA09DE62AQ40727618-B39C0783-D869-49B2-9D0E-AC79CC2FDF05Q40759551-37096FA1-8EBE-48C2-8B4E-8F6E51BE9C58Q41867892-DFEE211C-F2DC-4D24-98FD-EC812D8108CFQ41972518-0C8E6278-4D86-4F47-9CA8-9177A1FB03B0Q46403959-92A5F4CE-9CD8-459B-9C8B-96571AAB46F1
P2860
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@en
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@nl
type
label
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@en
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@nl
prefLabel
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@en
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@nl
P2093
P921
P356
P1433
P1476
Conjunctive enhancement of enz ...... te coronary artery thrombosis.
@en
P2093
P304
P356
10.1161/01.CIR.85.2.805
P407
P577
1992-02-01T00:00:00Z